Teva Pharmaceutical Industries Limited Announces Final Approval Of Meloxicam Tablets
JERUSALEM, Israel--(BUSINESS WIRE)--July 20, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that the U. S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for Meloxicam Tablets, 7.5 mg and 15 mg. Shipment of this product will begin immediately.